The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study

Clinical Pharmacology and Therapeutics

Volumn 49, Issue 3, 1991, Pages 322-329

  Moser, M ^a   Abraham, P A ^a   Bennett, W M ^a   Brachfeld, N ^a   Goodman, R P ^a   McKenney, J M ^a   Hollifield, J W ^a   Kirkendall, W M ^a   Lasseter, K C ^a   Leon, A S ^a   Lunn, J A ^a   Miller, K ^a   Morganroth, J ^a   Ruddy, M C ^a   Sambhi, M P ^a   Stein, W J ^a   Weber, M A ^a   Williams, R L ^a   Zawada, E T ^a   DeSilva, J ^a   Gourley, L A ^a   Whalen, J J ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; HYDROCHLOROTHIAZIDE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZATION;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; BLOOD PRESSURE; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGE; NEGROID RACE; RENIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026089081     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1991.36     Document Type: Article

References (10)